Records containing: Pulmonary Embolism
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2022-07-26Patient Safety Learning Laboratory: Improving Safety of Diagnosis and Therapy in the Inpatient Setting
-
CLINICAL_TRIALS study record update · 2022-07-26Ferumoxytol as a Contrast Agent for Pulmonary Magnetic Resonance Angiography
-
CLINICAL_TRIALS study record update · 2022-06-10Mexican Multidisciplinary Registry of Patients With Venous Thromboembolic Disease
-
CLINICAL_TRIALS study record update · 2022-05-26Low-molecular-weight Heparin to Prevent Recurrent VTE in Pregnancy: a Randomized Controlled Trial of Two Doses
-
CLINICAL_TRIALS study record update · 2022-05-19A Randomized, Double-blind Clinical Trial of Anticoagulation Therapy With Warfarin in Caribbean Hispanics: Comparison Between an Admixture-adjusted Pharmacogenetic-driven Warfarin Dose Refinement Algorithm and the Standard of Care
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2022-05-13Diagnostic Performances of Magnetic Resonance Imaging Combined With Venous Ultrasonography of the Legs for Pulmonary Embolism
-
CLINICAL_TRIALS study record update · 2022-05-04Pulmonary Embolism: Mechanism and Therapeutic Innovation
-
CLINICAL_TRIALS study record update · 2022-04-27Short-term Clinical Deterioration After Acute Pulmonary Embolism
-
CLINICAL_TRIALS study record update · 2022-04-26Pulmonary Embolism Short-term Clinical Outcomes Registry (PE-SCOR)
-
CLINICAL_TRIALS study record update · 2022-04-25Phase I Trial of Inhaled Nitric Oxide to Treat Acute Pulmonary Embolism
-
CLINICAL_TRIALS study record update · 2022-04-06A Single-Center, Blinded, Randomized Control Trial Evaluating Different Approaches to Evaluation of Right Ventricular Size and Function Using the Upper Valley Right Ventricle Algorithm and Novel Imaging Modalities
-
CLINICAL_TRIALS study record update · 2022-04-05Risk Stratification for Hospital-Acquired Venous Thromboembolism in Medical Patients: a Prospective Cohort Study
-
CLINICAL_TRIALS study record update · 2022-04-01Evaluation of Different Prognostic Tools in Patients With Acute Pulmonary Thromboembolism
-
CLINICAL_TRIALS study record update · 2022-03-24Retrospective Study: Rivaroxaban Utilization for Treatment and Prevention of Thromboembolism in Cancer Patients: Experience at a Comprehensive Cancer Center
-
CLINICAL_TRIALS study record update · 2022-03-17Symptom-related Screening Program Following Pulmonary Embolism for Early Detection of Chronic ThromboEmbolic Pulmonary Hypertension (CTEPH)
-
CLINICAL_TRIALS study record update · 2022-02-15Non-invasive Diagnosis of Pulmonary Embolism by Use of Biomarkers in Exhaled Breath Condensate
-
CLINICAL_TRIALS study record update · 2022-02-03The Use of a Monitoring Device by General Practitioners During Out-of-hours Care: Protocol of a Prospective Randomised Controlled Trial
-
CLINICAL_TRIALS study record update · 2022-01-11Cook IVC Filter Study
-
CLINICAL_TRIALS study record update · 2021-12-29Catheter-Directed Thrombolysis Versus ANticoagulation Monotherapy in Patients With Acute Intermediate-High Risk PulmonarY Embolism: The CANARY Randomized Clinical Trial
-
CLINICAL_TRIALS study record update · 2021-12-23An Exploratory Study of the Pharmacokinetics of Apixaban in Patients Undergoing Pancreaticoduodenectomy
-
CLINICAL_TRIALS study record update · 2021-12-09PET / CT Scan to Detect Cancer in Patients With Unprovoked Venous Thromboembolic Disease. Open Randomized Clinical Trial.
-
CLINICAL_TRIALS study record update · 2021-11-22A PHASE IV NON-INTERVENTIONAL STUDY. ADVERSE EVENTS (AES)/SUSPECTED ADVERSE DRUG REACTIONS (SADRS) ON THE PREVENTION OF STROKE AND SYSTEMIC EMBOLISM IN ADULT PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION WITH ONE OR MORE RISK FACTORS AS PRIOR STOKE OR TRANSIENT ISCHAEMIC ATTACK; AGE >75; HYPERTENSION; DIABETES MELLITUS; SYMPTOMATIC HEART FAILURE (NYHA CLASS >II) AND PREVENTION OF VENOUS THROMBOEMBOLIC EVENTS (VTE) IN ADULT PATIENTS WHO HAVE UNDERGONE ELECTIVE HIP OR KNEE REPLACEMENT SURGERY UNDER TREATMENT WITH ELICUIS (REGISTERED) (APIXABAN)
-
CLINICAL_TRIALS study record update · 2021-11-18Prevalence and Severity of Venous Thromboembolism in a General Population During the COVID-19 Pandemic
-
CLINICAL_TRIALS study record update · 2021-11-11A PHASE IV NON-INTERVENTIONAL STUDY. REGISTRY OF ADVERSE EVENTS (AES)/SUSPECTED ADVERSE DRUG REACTIONS (SADRS) OF ADULT PATIENTS UNDER TREATMENT OF DEEP VEIN THROMBOSIS (DVT) AND PULMONARY EMBOLISM (PE); PREVENTION OF RECURRENT DVT AND PE WITH ELICUIS REGISTERED (APIXABAN)
-
CLINICAL_TRIALS study record update · 2021-11-11Registration of the Major Adverse Cardiovascular Events and Pulmonary Embolism in Primary Total Joint Arthroplasty